Chugai Pharmaceutical Co., Ltd.
$51.14+4.80%(+$2.34)
TickerSpark Score
71/100
57
Valuation
100
Profitability
70
Growth
100
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CHGCF research report →
52-Week Range42% of range
Low $39.03
Current $51.14
High $68.08
Companywww.chugai-pharm.co.jp
Chugai Pharmaceutical Co. , Ltd. , together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
- CEO
- Osamu Okuda
- IPO
- 2012
- Employees
- 5,026
- HQ
- Chuo, JP
Price Chart
-6.42% · this period
Valuation
- Market Cap
- $84.16B
- P/E
- 28.81
- P/S
- 10.09
- P/B
- 6.83
- EV/EBITDA
- 18.95
- Div Yield
- 3.44%
Profitability
- Gross Margin
- 71.45%
- Op Margin
- 47.55%
- Net Margin
- 35.02%
- ROE
- 23.16%
- ROIC
- 23.03%
Growth & Income
- Revenue
- $1.26T · 7.55%
- Net Income
- $434.39B · 12.15%
- EPS
- $263.96 · 12.16%
- Op Income
- $590.71B
- FCF YoY
- -20.18%
Performance & Tape
- 52W High
- $68.08
- 52W Low
- $39.03
- 50D MA
- $53.99
- 200D MA
- $51.81
- Beta
- 0.56
- Avg Volume
- 7.05K
Get TickerSpark's AI analysis on CHGCF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CHGCF Coverage
We haven't published any research on CHGCF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CHGCF Report →